Aquestive Therapeutics (AQST) Other Accumulated Expenses (2017 - 2026)
Aquestive Therapeutics' Other Accumulated Expenses was $1.72 million in Q4 2020, up 46.7% from $1.17 million a year earlier and up 4.0% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
From Q4 2017 onward, Aquestive Therapeutics has reported Other Accumulated Expenses for 12 quarters.
- Other Accumulated Expenses has now increased for three consecutive years, with a three-year compound annual growth rate of 97.1% (FY2017 to FY2020).
- In earlier years, Other Accumulated Expenses was $1.17 million in FY2019 (+144.1%), $481,000 in FY2018 (+113.8%) and $225,000 in FY2017.
- The Q4 2020 figure marks the highest quarterly Other Accumulated Expenses in data going back to Q4 2017.
- Compared with a year earlier, Other Accumulated Expenses has increased for seven straight quarters, with growth averaging 134.9% over the last seven quarters.
- Across the past five years, year-over-year growth in Other Accumulated Expenses ran from 46.7% in Q4 2020 to 309.7% in Q3 2019.
- Per Business Quant data, AQST's Other Accumulated Expenses in the three quarters before Q4 2020 was $1.66 million (Q3 2020), $1.4 million (Q2 2020) and $1.41 million (Q1 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Aquestive Therapeutics | 442.42 Mn | 21.68 Mn | 3.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 157,000.00 |
| Jun 30, 2026 | 51,000.00 |
| Sep 30, 2025 | 561,000.00 |
| Jun 30, 2025 | 364,000.00 |
| Mar 31, 2025 | 89,000.00 |
| Dec 31, 2024 | 87,000.00 |
| Dec 31, 2020 | 1.72 Mn |
| Sep 30, 2020 | 1.66 Mn |
| Jun 30, 2020 | 1.40 Mn |
| Mar 31, 2020 | 1.41 Mn |
| Dec 31, 2019 | 1.17 Mn |
| Sep 30, 2019 | 1.06 Mn |
| Jun 30, 2019 | 809,000.00 |
| Mar 31, 2019 | 641,000.00 |
| Dec 31, 2018 | 481,000.00 |
| Sep 30, 2018 | 258,000.00 |
| Jun 30, 2018 | 275,000.00 |
| Dec 31, 2017 | 225,000.00 |
API Access
Aquestive Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();